Dwayne Johnson is revealing his struggles with depression. Johnson shared on "The Pivot" podcast that he's had "three bouts of depression" over the years. "The first time depression hit me I was ...

Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...

NEW YORK (WPIX) – The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday. Spravato is a first-of-its-kind medication to ...

Johnson & Johnson has received FDA approval for Spravato nasal spray as the first and only monotherapy for adults with treatment-resistant depression. The approval follows a priority review and is ...

The Food and Drug Administration on Tuesday approved Johnson & Johnson's nasal spray to be used alone in adults with a major depressive disorder that is difficult to treat, as sales of the drug ...

Johnson & Johnson asked the FDA to approve its nasal spray, Spravato, as therapy for treatment-resistant depression. Nearly 30% of the estimated 280 million people worldwide living with major ...

The Food and Drug Administration on Tuesday approved Johnson & Johnson's nasal spray to be used alone in adults with a major depressive disorder that is difficult to treat, as sales of the drug ...

NEW YORK (WPIX) – The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday. Spravato is a first-of-its-kind medication to ...

Updated: Jan 21, 2025 / 04:56 PM CST NEW YORK (WPIX) – The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday.

By Annika Kim Constantino,CNBC • Published January 21, 2025 • Updated on January 21, 2025 at 10:04 am ...